Skip to content

Impact of Interventional Revascularization on the Physiological Assessment of Bystander Coronary Lesions by FFR

Impact of Interventional Revascularization on the Physiological Assessment of Bystander Coronary Lesions by FFR (ABC-FFR)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07314879
Acronym
ABC-FFR
Enrollment
160
Registered
2026-01-02
Start date
2020-06-10
Completion date
2025-06-26
Last updated
2026-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

Intracoronary Pressure Measurement, Fractional Flow Reserve (FFR), Instantaneous Wave-Free Ratio (iFR), Resting Full-Cycle Ratio (RFR), Chronic Coronary Syndrome (CCS), Cardiology

Brief summary

The ABC-FFR trial examines the understudied hemodynamic interaction between parallel coronary stenoses, as the physiological impact of treating one lesion on the pressure indices of lesions in separate parallel branches is not yet fully understood. This prospective, multicenter study enrolls patients scheduled for percutaneous coronary intervention (PCI) of a designated index lesion who also present with a concurrent remote stenosis in a parallel coronary artery. It evaluates potential changes in fractional flow reserve (FFR) and non-hyperemic pressure ratio (NHPR) measurements within the remote lesion both before and after the index lesion is revascularized.

Interventions

DIAGNOSTIC_TESTHemodynamic Evaluation of Remote Lesion before & after PCI of Index Lesion

Initial hemodynamic evaluation of the remote, parallel lesion, followed by the planned percutaneous coronary intervention of the index lesion, and a final hemodynamic reevaluation of the remote lesion

Sponsors

University of Erlangen-Nürnberg Medical School
CollaboratorOTHER
University Hospital Erlangen
CollaboratorOTHER
Friedrich-Alexander-Universität Erlangen-Nürnberg
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Scheduled percutaneous coronary intervention for at least one coronary lesion (as indicated by evidence of myocardial ischemia on non-invasive stress imaging, an angiographic stenosis severity \>90% diameter stenosis, or an hemodynamically significant intracoronary pressure measurement) * Additional stenosis of ≥ 30% diameter stenosis in a parallel coronary artery anatomically suitable for wire-based intracoronary pressure assessment

Exclusion criteria

* ST-elevation myocardial infarction * Non-ST-elevation myocardial infarction with immediate invasive strategy recommended by current ESC guidelines (e.g. due to hemodynamic instability, cardiogenic shock, acute heart failure presumed secondary to ongoing myocardial ischemia, recurrent or ongoing chest pain refractory to medical treatment, or life-threatening arrhythmias or cardiac arrest after presentation) * Acute totally occluded coronary artery * Unsuitability for intracoronary measurement of FFR (e.g. due to contraindications for the administration of adenosine)

Design outcomes

Primary

MeasureTime frameDescription
Change in Hemodynamic Classification by FFRBaselineChange in hemodynamic classification of the remote lesion with fractional flow reserve after percutaneous coronary intervention of the index lesion
ΔFFRBaselineDifference between fractional flow reserve measurements in the remote lesion after and before percutaneous coronary intervention of the index lesion

Secondary

MeasureTime frameDescription
ΔNHPRBaselineDifference between non-hyperemic pressure ratio measurements in the remote lesion after and before percutaneous coronary intervention of the index lesion
Change in Hemodynamic Classification by NHPRBaselineChange in hemodynamic classification of the remote lesion with non-hyperemic pressure ratios after percutaneous coronary intervention of the index lesion

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026